Key result
Heavy calcification (OR 16; 95% CI 1.87-357) and homograft conduit (OR 4.37; 95% CI 1.1-17.8) were significant predictors of conduit rupture during transcatheter RVOT treatment.
Cohort (n=99)
Yes
Odds Ratio: 16 (95% CI 1.87–357)
p-value: p=<0.05
No takes yet. Share an insight, caveat, or question.
Heavy calcification and homograft conduits strongly predict conduit rupture during percutaneous pulmonary valve implantation, highlighting the need for careful patient selection and preparedness for targeted interventions.
Boudjemline et al. (2016) conducted a cohort in Right ventricular outflow tract (RVOT) transcatheter treatment (n=99). Heavy calcification vs. Absence of heavy calcification was evaluated on Conduit rupture (OR 16, 95% CI 1.87-357, p=<0.05). Heavy calcification (OR 16; 95% CI 1.87-357) and homograft conduit (OR 4.37; 95% CI 1.1-17.8) were significant predictors of conduit rupture during transcatheter RVOT treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: